Literature DB >> 17703289

Intracellular localization of human respiratory syncytial virus L protein.

C Carromeu1, F M Simabuco, R E Tamura, L E Farinha Arcieri, A M Ventura.   

Abstract

Replication and transcription of the human respiratory syncytial virus (hRSV) genome is carried out by the ribonucleocapsid complex (RNA together with N, P, M2-1 and L proteins), with the L protein being responsible for all enzymatic activities. In the present study, we obtained anti-L polyclonal sera in mice. These antibodies were functional in immunofluorescence and Western blotting assays in hRSV-infected HEp-2 cells. In the immunofluorescence assays, we detected inclusion bodies in the anti-L staining, similar to the ones seen by anti-N or anti-P staining. The results presented here provide the first evidence of the intracellular localization of the hRSV L protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703289     DOI: 10.1007/s00705-007-1048-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly.

Authors:  Anuradha Radhakrishnan; Dawn Yeo; Gaie Brown; Myint Zu Myaing; Laxmi Ravi Iyer; Roland Fleck; Boon-Huan Tan; Jim Aitken; Duangmanee Sanmun; Kai Tang; Andy Yarwood; Jacob Brink; Richard J Sugrue
Journal:  Mol Cell Proteomics       Date:  2010-06-08       Impact factor: 5.911

2.  The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism.

Authors:  Pradyumna S Baviskar; Anne L Hotard; Martin L Moore; Antonius G P Oomens
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

3.  Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein.

Authors:  Dongsheng Li; David A Jans; Phillip G Bardin; Jayesh Meanger; John Mills; Reena Ghildyal
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

4.  Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS.

Authors:  Aaron W Lifland; Jeenah Jung; Eric Alonas; Chiara Zurla; James E Crowe; Philip J Santangelo
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

Review 5.  To assemble or not to assemble: The changing rules of pneumovirus transmission.

Authors:  Nicolás Cifuentes-Muñoz; Rebecca Ellis Dutch
Journal:  Virus Res       Date:  2019-03-05       Impact factor: 3.303

6.  Upon Infection, Cellular WD Repeat-Containing Protein 5 (WDR5) Localizes to Cytoplasmic Inclusion Bodies and Enhances Measles Virus Replication.

Authors:  Dzwokai Ma; Cyril X George; Jason L Nomburg; Christian K Pfaller; Roberto Cattaneo; Charles E Samuel
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

7.  The Thr205 phosphorylation site within respiratory syncytial virus matrix (M) protein modulates M oligomerization and virus production.

Authors:  M Bajorek; L Caly; K C Tran; G N Maertens; R A Tripp; E Bacharach; M N Teng; R Ghildyal; D A Jans
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

8.  Mechanism of action for respiratory syncytial virus inhibitor RSV604.

Authors:  SreeRupa Challa; Andrew D Scott; Olga Yuzhakov; Ying Zhou; Choi Lai Tiong-Yip; Ning Gao; Jason Thresher; Qin Yu
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

Review 9.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

10.  p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly.

Authors:  Jens Fricke; Lily Y Koo; Charles R Brown; Peter L Collins
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.